FDA approved Tylenol With Naproxen, the first fixed-dose OTC combination of acetaminophen and naproxen sodium. Learn who may use it, why duplicate ingredients matter, and the key safety warnings.
On July 24, 2026, the FDA approved Tylenol With Naproxen, the first nonprescription fixed-dose product to combine acetaminophen (650 mg) and naproxen sodium (220 mg) in one pill.
It is approved for temporary relief of minor aches and pains in adults and children 12 and older. The combination is designed to offer relatively fast onset from acetaminophen with longer-lasting anti-inflammatory pain relief from naproxen—up to 12 hours per dose when used exactly as labeled.
People have long sometimes taken acetaminophen and an NSAID separately. A fixed-dose product can be more convenient, but convenience does not remove the safety considerations of either ingredient. The most important practical rule is to avoid unintentionally taking more acetaminophen or naproxen from another cold, flu, sleep, headache, or pain product.
Talk with a pharmacist or clinician first if you:
Naproxen is an NSAID. Serious but uncommon risks include stomach bleeding, kidney problems, and cardiovascular events. Acetaminophen overdose can cause severe liver injury. Seek urgent care for black stools, vomiting blood, chest pain, trouble breathing, facial swelling, yellowing of skin or eyes, or a suspected overdose.
Do not attempt to recreate the product by combining loose acetaminophen and naproxen tablets. The approved product has a specific fixed dose and label. A pharmacist can help you compare it with other products and avoid duplicate ingredients.
Tylenol With Naproxen gives consumers a new opioid-free OTC option for temporary minor pain. It is still real medicine, not a wellness supplement. Read the Drug Facts label, use the lowest effective dose for the shortest time, and ask a pharmacist when other medicines or health conditions are part of the picture.